Early detection is the key to preserving sight. We find early signs of chronic disease, led by our FDA-cleared AI for Diabetic Retinopathy.
The retina is the fastest way to detect diabetic retinopathy.
Combat this disease with the power of early intervention.
Close the gap in diabetic eye care with FDA-cleared diagnostic results in under 30 seconds
Halt disease progression through early detection, allowing for timely treatment that can preserve a patient’s sight
Bridge the massive access gap for the millions of patients who do not currently receive care from an eye specialist
Normalize universal screening by bringing autonomous, expert-level AI diagnostics to every routine primary care visit
Explore Diabetic Retinopathy.
Protect central vision through proactive identification and specialist-led care.
Detect signs of intermediate and late AMD with a retinal scan, flagging high-risk findings for prioritized specialist validation
Enable proactive care to preserve central vision and protect a patient’s long-term independence and quality of life
Triage suspected findings automatically to ensure patients with macular changes are fast-tracked for expert clinical review
Reach underserved populations by identifying AMD signs during routine exams, bridging the gap for those without specialist care
Explore AMD
Detect the “silent thief of sight” before permanent damage occurs.
Flag suspected indicators of Glaucomatous Optic Nerve Damage (GOND) during a routine exam, triggering an automated triage for expert human verification
Identify structural risks like optic disc cupping early, allowing for timely treatment to prevent irreversible vision loss
Expand access to glaucoma detection by utilizing the same retinal scan already used for standard DR screening
Ensure clinical safety with a workflow that recommends specialist referral whenever high-risk GOND signs are detected
Explore Glaucoma.
The retina is linked to many serious conditions. Eyenuk is expanding its platform to support broader early-warning and monitoring use cases as new AI models receive clinical and regulatory validation.
View Clinical Evidence.
Start FDA-cleared autonomous diabetic retinopathy screening in your clinic today.